Sotera Health (NASDAQ:SHC) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Sotera Health (NASDAQ:SHC) have received a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $15.92.

SHC has been the subject of several research reports. Royal Bank of Canada reiterated an “outperform” rating and issued a $17.00 price target on shares of Sotera Health in a research report on Thursday, November 21st. The Goldman Sachs Group initiated coverage on shares of Sotera Health in a research report on Friday, December 6th. They issued a “neutral” rating and a $14.00 price target for the company. Finally, Barclays reduced their price target on shares of Sotera Health from $17.00 to $16.00 and set an “overweight” rating for the company in a research report on Friday, February 28th.

Hedge Funds Weigh In On Sotera Health

A number of large investors have recently bought and sold shares of the company. Darsana Capital Partners LP raised its position in Sotera Health by 716.9% during the 3rd quarter. Darsana Capital Partners LP now owns 20,010,000 shares of the company’s stock worth $334,167,000 after buying an additional 17,560,636 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Sotera Health by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 14,923,546 shares of the company’s stock worth $204,154,000 after purchasing an additional 173,341 shares during the period. Sessa Capital IM L.P. grew its stake in shares of Sotera Health by 46.5% during the 3rd quarter. Sessa Capital IM L.P. now owns 6,300,597 shares of the company’s stock worth $105,220,000 after purchasing an additional 2,000,000 shares during the period. Sculptor Capital LP acquired a new position in shares of Sotera Health during the 4th quarter worth $68,400,000. Finally, State Street Corp grew its stake in shares of Sotera Health by 18.5% during the 3rd quarter. State Street Corp now owns 4,126,806 shares of the company’s stock worth $68,918,000 after purchasing an additional 644,236 shares during the period. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Stock Up 0.5 %

Shares of NASDAQ:SHC opened at $11.99 on Wednesday. The company has a market capitalization of $3.40 billion, a PE ratio of 47.96 and a beta of 1.92. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. Sotera Health has a twelve month low of $10.71 and a twelve month high of $17.08. The firm has a 50 day simple moving average of $13.01 and a 200-day simple moving average of $14.21.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.